HRP20130941T1 - Citratna sol 9e-15-(2-pirolidin-1-iletoksi)-7,12,25-trioksa-19,21,24-triazatetraciklo[18.3.1.1(2,5).1(14,18)]heksakoza-1(24),2,4,9,14,16,18(26),20,22-nonaena - Google Patents
Citratna sol 9e-15-(2-pirolidin-1-iletoksi)-7,12,25-trioksa-19,21,24-triazatetraciklo[18.3.1.1(2,5).1(14,18)]heksakoza-1(24),2,4,9,14,16,18(26),20,22-nonaena Download PDFInfo
- Publication number
- HRP20130941T1 HRP20130941T1 HRP20130941AT HRP20130941T HRP20130941T1 HR P20130941 T1 HRP20130941 T1 HR P20130941T1 HR P20130941A T HRP20130941A T HR P20130941AT HR P20130941 T HRP20130941 T HR P20130941T HR P20130941 T1 HRP20130941 T1 HR P20130941T1
- Authority
- HR
- Croatia
- Prior art keywords
- salt
- scale
- ray diffraction
- salt according
- triazatetracyclo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22560909P | 2009-07-15 | 2009-07-15 | |
| PCT/SG2010/000265 WO2011008172A1 (en) | 2009-07-15 | 2010-07-14 | 9e-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza- tetracyclo[18.3.1.1(2,5).1(14)18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20130941T1 true HRP20130941T1 (hr) | 2013-11-08 |
Family
ID=42790728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20130941AT HRP20130941T1 (hr) | 2009-07-15 | 2010-07-14 | Citratna sol 9e-15-(2-pirolidin-1-iletoksi)-7,12,25-trioksa-19,21,24-triazatetraciklo[18.3.1.1(2,5).1(14,18)]heksakoza-1(24),2,4,9,14,16,18(26),20,22-nonaena |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9062074B2 (https=) |
| EP (1) | EP2454266B1 (https=) |
| JP (2) | JP6013911B2 (https=) |
| CN (1) | CN102762577B (https=) |
| AR (2) | AR077483A1 (https=) |
| BR (1) | BR112012000750B1 (https=) |
| CA (1) | CA2768210C (https=) |
| DK (1) | DK2454266T3 (https=) |
| ES (1) | ES2429525T3 (https=) |
| HR (1) | HRP20130941T1 (https=) |
| MX (1) | MX2012000680A (https=) |
| PL (1) | PL2454266T3 (https=) |
| PT (1) | PT2454266E (https=) |
| RU (1) | RU2543721C2 (https=) |
| SI (1) | SI2454266T1 (https=) |
| SM (1) | SMT201300112B (https=) |
| TW (1) | TWI537276B (https=) |
| WO (1) | WO2011008172A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2017112748A (ru) | 2014-11-17 | 2018-12-19 | Арно Терапьютикс, Инк. | Композиции онапристона пролонгированного действия и способы |
| CA2998924A1 (en) | 2015-09-25 | 2017-03-30 | Context Biopharma Inc. | Methods of making onapristone intermediates |
| CA3008422A1 (en) | 2015-12-15 | 2017-06-22 | Context Biopharma Inc. | Amorphous onapristone compositions and methods of making the same |
| US20180148471A1 (en) | 2016-11-30 | 2018-05-31 | Arno Therapeutics, Inc. | Methods for onapristone synthesis dehydration and deprotection |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY110603A (en) * | 1993-05-27 | 1998-08-29 | Novartis Ag | Tetrahydropyran derivatives |
| WO2004078682A2 (en) | 2003-03-05 | 2004-09-16 | Irm Llc | Cyclic compounds and compositions as protein kinase inhibitors |
| WO2007058627A1 (en) | 2005-11-16 | 2007-05-24 | S*Bio Pte Ltd | Oxygen linked pyrimidine derivatives |
-
2010
- 2010-07-14 ES ES10737645T patent/ES2429525T3/es active Active
- 2010-07-14 RU RU2012105044/04A patent/RU2543721C2/ru active
- 2010-07-14 PT PT107376451T patent/PT2454266E/pt unknown
- 2010-07-14 DK DK10737645.1T patent/DK2454266T3/da active
- 2010-07-14 WO PCT/SG2010/000265 patent/WO2011008172A1/en not_active Ceased
- 2010-07-14 CN CN201080032627.5A patent/CN102762577B/zh active Active
- 2010-07-14 US US13/384,139 patent/US9062074B2/en active Active
- 2010-07-14 BR BR112012000750-5A patent/BR112012000750B1/pt active IP Right Grant
- 2010-07-14 JP JP2012520571A patent/JP6013911B2/ja active Active
- 2010-07-14 MX MX2012000680A patent/MX2012000680A/es active IP Right Grant
- 2010-07-14 EP EP10737645.1A patent/EP2454266B1/en active Active
- 2010-07-14 PL PL10737645T patent/PL2454266T3/pl unknown
- 2010-07-14 SI SI201030347T patent/SI2454266T1/sl unknown
- 2010-07-14 CA CA2768210A patent/CA2768210C/en active Active
- 2010-07-14 HR HRP20130941AT patent/HRP20130941T1/hr unknown
- 2010-07-15 AR ARP100102594A patent/AR077483A1/es not_active Application Discontinuation
- 2010-07-15 TW TW099123331A patent/TWI537276B/zh active
-
2013
- 2013-10-04 SM SM201300112T patent/SMT201300112B/xx unknown
-
2015
- 2015-05-07 JP JP2015094972A patent/JP2015164941A/ja active Pending
-
2019
- 2019-08-05 AR ARP190102219A patent/AR114987A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2429525T3 (es) | 2013-11-15 |
| AR077483A1 (es) | 2011-08-31 |
| RU2012105044A (ru) | 2013-08-20 |
| US9062074B2 (en) | 2015-06-23 |
| SI2454266T1 (sl) | 2013-10-30 |
| CN102762577B (zh) | 2015-01-07 |
| HK1178159A1 (en) | 2013-09-06 |
| EP2454266B1 (en) | 2013-07-10 |
| SMT201300112B (it) | 2013-11-08 |
| PL2454266T3 (pl) | 2014-01-31 |
| CA2768210C (en) | 2017-08-15 |
| PT2454266E (pt) | 2013-10-10 |
| DK2454266T3 (da) | 2013-09-08 |
| BR112012000750A2 (pt) | 2016-08-09 |
| AR114987A2 (es) | 2020-11-11 |
| BR112012000750A8 (pt) | 2018-02-06 |
| CN102762577A (zh) | 2012-10-31 |
| TWI537276B (zh) | 2016-06-11 |
| WO2011008172A1 (en) | 2011-01-20 |
| JP6013911B2 (ja) | 2016-10-25 |
| RU2543721C2 (ru) | 2015-03-10 |
| US20120196876A1 (en) | 2012-08-02 |
| CA2768210A1 (en) | 2011-01-20 |
| EP2454266A1 (en) | 2012-05-23 |
| JP2012533539A (ja) | 2012-12-27 |
| TW201107336A (en) | 2011-03-01 |
| JP2015164941A (ja) | 2015-09-17 |
| BR112012000750B1 (pt) | 2021-05-25 |
| MX2012000680A (es) | 2012-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20151324T1 (hr) | Soli nilotiniba i njihovi kristalni oblici | |
| HRP20121028T1 (hr) | Kristalni oblici febuksostata | |
| TWI562991B (en) | Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same | |
| PT2640262E (pt) | Sensor para a aquisição de sinais fisiológicos | |
| EG26786A (en) | Fertilizers contain sulfur and process to manufacture | |
| HRP20150771T1 (hr) | Spoj za inhibiciju notch signalnog puta | |
| IL228805A0 (en) | Tissue for the acquisition of physiological signals | |
| JP2011006431A5 (https=) | ||
| ME02805B (me) | Inhibitori cdc7 | |
| AP2013006767A0 (en) | 2'-Fluoro substituted carbanucleoside analogs for antiviral treatment | |
| FR2962731B1 (fr) | Procede de preparation de derives d'amino-benzoyl-benzofurane | |
| ZA201107350B (en) | Imidazo [2 1 b] [1, 3, 4] thiadiazole derivatives | |
| SI2744802T1 (sl) | Spojine za vezavo na trombocitno specifičen glikoprotein IIB/IIIA in njihova uporaba za prikazovanje strdkov | |
| GB0910406D0 (en) | Three-dimensional direction indicator | |
| SG175066A1 (en) | 6'-sialyllactose salts and process for their synthesis and for the synthesis of other a-sialyloligosaccharides | |
| HRP20130941T1 (hr) | Citratna sol 9e-15-(2-pirolidin-1-iletoksi)-7,12,25-trioksa-19,21,24-triazatetraciklo[18.3.1.1(2,5).1(14,18)]heksakoza-1(24),2,4,9,14,16,18(26),20,22-nonaena | |
| FR3002733B1 (fr) | Nouveau sel de l'abexinostat, forme cristalline associee,leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| ZA201203359B (en) | Process for the preparation of a powder comprising one or more complexing agent salts | |
| HRP20150356T1 (hr) | Kristalni oblici soli prasugrela | |
| FR2947265B1 (fr) | Procede de preparation d'alkylalcanolamines | |
| EP2655364A4 (en) | PROCESS FOR THE PREPARATION OF LAPATINIB AND ITS DITOSYLATE SALT | |
| FR2935701B1 (fr) | Procede de preparation de composes fluores olefiniques | |
| IL223752A0 (en) | Delta crystalline form of the arginine salt of perindopril, a process for its preparation, and pharmaceutical preparations containing it | |
| ZA201105124B (en) | Process for the preparation of rosuvastatin salts | |
| FR2935702B1 (fr) | Procede de preparation de composes fluores olefiniques |